A Trinity Nano-Vaccine System with Spatiotemporal Immune Effect for the Adjuvant Cancer Therapy after Radiofrequency...

Area of Science:

• Immunology
• Nanotechnology
• Oncology

Background:

• Cancer vaccines face challenges with sustained immune activity and efficacy, often inversely related to tumor burden.
• Existing strategies struggle to prolong the effectiveness of vaccine-induced immunity against cancer recurrence and metastasis.

Purpose of the Study:

• To develop a priming-boosting vaccination strategy combined with radiofrequency ablation (RFA) to enhance long-term cancer vaccine efficacy.
• To construct and evaluate a novel bisphosphonate nanovaccine (BNV) system for sustained antitumor immunity.

Main Methods:

• Designed a bisphosphonate nanovaccine (BNV) system with dual electric potentials (BNV(+&-)) acting as an immune adjuvant by blocking mevalonate metabolism.
• Investigated the spatial and temporal heterogeneity of BNV(+/-) lymphatic delivery and immune activity.
• Integrated the BNV system with radiofrequency ablation (RFA) therapy in a preclinical model of colorectal cancer liver metastases.

Main Results:

• BNV(+) and BNV(-) components exhibited distinct lymphatic drainage and retention patterns, leading to alternately induced immune responses.
• The combined RFA and BNV strategy significantly suppressed the recurrence and metastasis of colorectal cancer liver metastases.
• The developed system demonstrated prolonged time-effectiveness of antitumor immunity.

Conclusions:

• The trinity system integrating RFA therapy, bisphosphonate adjuvant, and spatiotemporal immune effects offers a promising approach for sustainable cancer vaccine regulation.
• This strategy provides a new orientation for precise delivery and enhanced efficacy of cancer vaccines, particularly in managing residual disease after ablation therapy.